<h1>Chemical manufacturer launches ?121.03 crore IPO for expansion, debt repayment and working capital; 75% QIB, 10% retail</h1> The company, a chemical manufacturer of high-purity pharmaceutical intermediates, opened an IPO on August 26, 2025 to raise up to ?121.03 crore via 13,300,000 equity shares (face value ?10) at a price band of ?86-91 per share, to be listed on NSE and BSE. Allocation: 75% to qualified institutional buyers, 15% to non-institutional investors and 10% to individual investors; the anchor portion ran Aug 25-29, 2025. Net proceeds will fund manufacturing capital expenditure, repay or prepay secured borrowings, support working capital and general corporate purposes. A book-running lead manager and registrar are appointed.